nodes	percent_of_prediction	percent_of_DWPC	metapath
Loteprednol—NR3C1—hematologic cancer	0.106	1	CbGaD
Loteprednol—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0731	0.209	CiPCiCtD
Loteprednol—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0731	0.209	CiPCiCtD
Loteprednol—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0706	0.202	CiPCiCtD
Loteprednol—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0684	0.195	CiPCiCtD
Loteprednol—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0646	0.185	CiPCiCtD
Loteprednol—Betamethasone—hematologic cancer	0.052	0.208	CrCtD
Loteprednol—Dexamethasone—hematologic cancer	0.052	0.208	CrCtD
Loteprednol—Triamcinolone—hematologic cancer	0.0508	0.203	CrCtD
Loteprednol—Prednisone—hematologic cancer	0.0482	0.193	CrCtD
Loteprednol—Prednisolone—hematologic cancer	0.0471	0.188	CrCtD
Loteprednol—NR3C1—Triamcinolone—hematologic cancer	0.0233	0.25	CbGbCtD
Loteprednol—NR3C1—Betamethasone—hematologic cancer	0.02	0.214	CbGbCtD
Loteprednol—NR3C1—Prednisolone—hematologic cancer	0.0197	0.211	CbGbCtD
Loteprednol—NR3C1—Prednisone—hematologic cancer	0.0186	0.2	CbGbCtD
Loteprednol—NR3C1—Dexamethasone—hematologic cancer	0.0116	0.125	CbGbCtD
Loteprednol—Exemestane—Prednisone—hematologic cancer	0.00273	0.0149	CrCrCtD
Loteprednol—Exemestane—Prednisolone—hematologic cancer	0.00266	0.0146	CrCrCtD
Loteprednol—Potassium Canrenoate—Prednisone—hematologic cancer	0.00206	0.0113	CrCrCtD
Loteprednol—Potassium Canrenoate—Prednisolone—hematologic cancer	0.00201	0.011	CrCrCtD
Loteprednol—Ciclesonide—Prednisone—hematologic cancer	0.00181	0.00991	CrCrCtD
Loteprednol—Ciclesonide—Prednisolone—hematologic cancer	0.00177	0.00967	CrCrCtD
Loteprednol—Medrysone—Prednisolone—hematologic cancer	0.0017	0.0093	CrCrCtD
Loteprednol—Prednicarbate—Betamethasone—hematologic cancer	0.00154	0.00841	CrCrCtD
Loteprednol—Testolactone—Dexamethasone—hematologic cancer	0.00154	0.00841	CrCrCtD
Loteprednol—Prednicarbate—Dexamethasone—hematologic cancer	0.00154	0.00841	CrCrCtD
Loteprednol—Beclomethasone—Dexamethasone—hematologic cancer	0.00154	0.00841	CrCrCtD
Loteprednol—Testolactone—Betamethasone—hematologic cancer	0.00154	0.00841	CrCrCtD
Loteprednol—Beclomethasone—Betamethasone—hematologic cancer	0.00154	0.00841	CrCrCtD
Loteprednol—Hydrocortamate—Prednisone—hematologic cancer	0.00152	0.00829	CrCrCtD
Loteprednol—Beclomethasone—Triamcinolone—hematologic cancer	0.0015	0.00821	CrCrCtD
Loteprednol—Prednicarbate—Triamcinolone—hematologic cancer	0.0015	0.00821	CrCrCtD
Loteprednol—Testolactone—Triamcinolone—hematologic cancer	0.0015	0.00821	CrCrCtD
Loteprednol—Fluocortolone—Dexamethasone—hematologic cancer	0.00149	0.00816	CrCrCtD
Loteprednol—Fluocortolone—Betamethasone—hematologic cancer	0.00149	0.00816	CrCrCtD
Loteprednol—Hydrocortamate—Prednisolone—hematologic cancer	0.00148	0.00809	CrCrCtD
Loteprednol—Cortisone acetate—Prednisone—hematologic cancer	0.00147	0.00803	CrCrCtD
Loteprednol—Fluocortolone—Triamcinolone—hematologic cancer	0.00146	0.00798	CrCrCtD
Loteprednol—Alclometasone—Dexamethasone—hematologic cancer	0.00145	0.00794	CrCrCtD
Loteprednol—Alclometasone—Betamethasone—hematologic cancer	0.00145	0.00794	CrCrCtD
Loteprednol—Cortisone acetate—Prednisolone—hematologic cancer	0.00143	0.00784	CrCrCtD
Loteprednol—Prednicarbate—Prednisone—hematologic cancer	0.00143	0.00779	CrCrCtD
Loteprednol—Testolactone—Prednisone—hematologic cancer	0.00143	0.00779	CrCrCtD
Loteprednol—Alclometasone—Triamcinolone—hematologic cancer	0.00142	0.00776	CrCrCtD
Loteprednol—Amcinonide—Betamethasone—hematologic cancer	0.00141	0.00773	CrCrCtD
Loteprednol—Budesonide—Betamethasone—hematologic cancer	0.00141	0.00773	CrCrCtD
Loteprednol—Amcinonide—Dexamethasone—hematologic cancer	0.00141	0.00773	CrCrCtD
Loteprednol—Budesonide—Dexamethasone—hematologic cancer	0.00141	0.00773	CrCrCtD
Loteprednol—Fluoxymesterone—Betamethasone—hematologic cancer	0.00141	0.00773	CrCrCtD
Loteprednol—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00141	0.00773	CrCrCtD
Loteprednol—Testolactone—Prednisolone—hematologic cancer	0.00139	0.00761	CrCrCtD
Loteprednol—Beclomethasone—Prednisolone—hematologic cancer	0.00139	0.00761	CrCrCtD
Loteprednol—Prednicarbate—Prednisolone—hematologic cancer	0.00139	0.00761	CrCrCtD
Loteprednol—Fluocortolone—Prednisone—hematologic cancer	0.00138	0.00757	CrCrCtD
Loteprednol—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00138	0.00755	CrCrCtD
Loteprednol—Budesonide—Triamcinolone—hematologic cancer	0.00138	0.00755	CrCrCtD
Loteprednol—Amcinonide—Triamcinolone—hematologic cancer	0.00138	0.00755	CrCrCtD
Loteprednol—Flunisolide—Betamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Desonide—Betamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Desonide—Dexamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Clobetasol propionate—Betamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Flunisolide—Dexamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Fludrocortisone—Betamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Fludrocortisone—Dexamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Diflorasone—Betamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Diflorasone—Dexamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Prednisone—Betamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Prednisone—Dexamethasone—hematologic cancer	0.00138	0.00753	CrCrCtD
Loteprednol—Fluocortolone—Prednisolone—hematologic cancer	0.00135	0.00739	CrCrCtD
Loteprednol—Alclometasone—Prednisone—hematologic cancer	0.00135	0.00736	CrCrCtD
Loteprednol—Desonide—Triamcinolone—hematologic cancer	0.00134	0.00735	CrCrCtD
Loteprednol—Prednisone—Triamcinolone—hematologic cancer	0.00134	0.00735	CrCrCtD
Loteprednol—Diflorasone—Triamcinolone—hematologic cancer	0.00134	0.00735	CrCrCtD
Loteprednol—Flunisolide—Triamcinolone—hematologic cancer	0.00134	0.00735	CrCrCtD
Loteprednol—Fludrocortisone—Triamcinolone—hematologic cancer	0.00134	0.00735	CrCrCtD
Loteprednol—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00134	0.00735	CrCrCtD
Loteprednol—Paramethasone—Dexamethasone—hematologic cancer	0.00134	0.00734	CrCrCtD
Loteprednol—Paramethasone—Betamethasone—hematologic cancer	0.00134	0.00734	CrCrCtD
Loteprednol—Alclometasone—Prednisolone—hematologic cancer	0.00131	0.00719	CrCrCtD
Loteprednol—Paramethasone—Triamcinolone—hematologic cancer	0.00131	0.00717	CrCrCtD
Loteprednol—Budesonide—Prednisone—hematologic cancer	0.00131	0.00716	CrCrCtD
Loteprednol—Amcinonide—Prednisone—hematologic cancer	0.00131	0.00716	CrCrCtD
Loteprednol—Desoximetasone—Dexamethasone—hematologic cancer	0.00131	0.00716	CrCrCtD
Loteprednol—Desoximetasone—Betamethasone—hematologic cancer	0.00131	0.00716	CrCrCtD
Loteprednol—Desoximetasone—Triamcinolone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Amcinonide—Prednisolone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Budesonide—Prednisolone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Fluoxymesterone—Prednisolone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Triamcinolone—Dexamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Mometasone—Betamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Mometasone—Dexamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Fluorometholone—Betamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Triamcinolone—Betamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Fluorometholone—Dexamethasone—hematologic cancer	0.00128	0.00699	CrCrCtD
Loteprednol—Diflorasone—Prednisone—hematologic cancer	0.00128	0.00698	CrCrCtD
Loteprednol—Flunisolide—Prednisone—hematologic cancer	0.00128	0.00698	CrCrCtD
Loteprednol—Fludrocortisone—Prednisone—hematologic cancer	0.00128	0.00698	CrCrCtD
Loteprednol—Clobetasol propionate—Prednisone—hematologic cancer	0.00128	0.00698	CrCrCtD
Loteprednol—Desonide—Prednisone—hematologic cancer	0.00128	0.00698	CrCrCtD
Loteprednol—Rimexolone—Dexamethasone—hematologic cancer	0.00125	0.00683	CrCrCtD
Loteprednol—Rimexolone—Betamethasone—hematologic cancer	0.00125	0.00683	CrCrCtD
Loteprednol—Betamethasone—Dexamethasone—hematologic cancer	0.00125	0.00683	CrCrCtD
Loteprednol—Dexamethasone—Betamethasone—hematologic cancer	0.00125	0.00683	CrCrCtD
Loteprednol—Mometasone—Triamcinolone—hematologic cancer	0.00125	0.00683	CrCrCtD
Loteprednol—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00125	0.00683	CrCrCtD
Loteprednol—Fluorometholone—Triamcinolone—hematologic cancer	0.00125	0.00683	CrCrCtD
Loteprednol—Diflorasone—Prednisolone—hematologic cancer	0.00125	0.00681	CrCrCtD
Loteprednol—Flunisolide—Prednisolone—hematologic cancer	0.00125	0.00681	CrCrCtD
Loteprednol—Fludrocortisone—Prednisolone—hematologic cancer	0.00125	0.00681	CrCrCtD
Loteprednol—Clobetasol propionate—Prednisolone—hematologic cancer	0.00125	0.00681	CrCrCtD
Loteprednol—Desonide—Prednisolone—hematologic cancer	0.00125	0.00681	CrCrCtD
Loteprednol—Prednisone—Prednisolone—hematologic cancer	0.00125	0.00681	CrCrCtD
Loteprednol—Methyltestosterone—Prednisone—hematologic cancer	0.00124	0.0068	CrCrCtD
Loteprednol—Paramethasone—Prednisone—hematologic cancer	0.00124	0.0068	CrCrCtD
Loteprednol—Dexamethasone—Triamcinolone—hematologic cancer	0.00122	0.00667	CrCrCtD
Loteprednol—Rimexolone—Triamcinolone—hematologic cancer	0.00122	0.00667	CrCrCtD
Loteprednol—Betamethasone—Triamcinolone—hematologic cancer	0.00122	0.00667	CrCrCtD
Loteprednol—Methyltestosterone—Prednisolone—hematologic cancer	0.00121	0.00664	CrCrCtD
Loteprednol—Paramethasone—Prednisolone—hematologic cancer	0.00121	0.00664	CrCrCtD
Loteprednol—Desoximetasone—Prednisone—hematologic cancer	0.00121	0.00664	CrCrCtD
Loteprednol—Methylprednisolone—Dexamethasone—hematologic cancer	0.00119	0.00653	CrCrCtD
Loteprednol—Methylprednisolone—Betamethasone—hematologic cancer	0.00119	0.00653	CrCrCtD
Loteprednol—Triamcinolone—Prednisone—hematologic cancer	0.00119	0.00648	CrCrCtD
Loteprednol—Mometasone—Prednisone—hematologic cancer	0.00119	0.00648	CrCrCtD
Loteprednol—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00119	0.00648	CrCrCtD
Loteprednol—Fluorometholone—Prednisone—hematologic cancer	0.00119	0.00648	CrCrCtD
Loteprednol—Desoximetasone—Prednisolone—hematologic cancer	0.00119	0.00648	CrCrCtD
Loteprednol—Prednisolone—Betamethasone—hematologic cancer	0.00117	0.00639	CrCrCtD
Loteprednol—Prednisolone—Dexamethasone—hematologic cancer	0.00117	0.00639	CrCrCtD
Loteprednol—Methylprednisolone—Triamcinolone—hematologic cancer	0.00117	0.00638	CrCrCtD
Loteprednol—Betamethasone—Prednisone—hematologic cancer	0.00116	0.00633	CrCrCtD
Loteprednol—Dexamethasone—Prednisone—hematologic cancer	0.00116	0.00633	CrCrCtD
Loteprednol—Rimexolone—Prednisone—hematologic cancer	0.00116	0.00633	CrCrCtD
Loteprednol—Triamcinolone—Prednisolone—hematologic cancer	0.00116	0.00633	CrCrCtD
Loteprednol—Mometasone—Prednisolone—hematologic cancer	0.00116	0.00633	CrCrCtD
Loteprednol—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00116	0.00633	CrCrCtD
Loteprednol—Fluorometholone—Prednisolone—hematologic cancer	0.00116	0.00633	CrCrCtD
Loteprednol—Prednisolone—Triamcinolone—hematologic cancer	0.00114	0.00625	CrCrCtD
Loteprednol—Dexamethasone—Prednisolone—hematologic cancer	0.00113	0.00618	CrCrCtD
Loteprednol—Rimexolone—Prednisolone—hematologic cancer	0.00113	0.00618	CrCrCtD
Loteprednol—Betamethasone—Prednisolone—hematologic cancer	0.00113	0.00618	CrCrCtD
Loteprednol—Hydrocortisone—Betamethasone—hematologic cancer	0.00112	0.00614	CrCrCtD
Loteprednol—Hydrocortisone—Dexamethasone—hematologic cancer	0.00112	0.00614	CrCrCtD
Loteprednol—Methylprednisolone—Prednisone—hematologic cancer	0.00111	0.00606	CrCrCtD
Loteprednol—Hydrocortisone—Triamcinolone—hematologic cancer	0.0011	0.006	CrCrCtD
Loteprednol—Prednisolone—Prednisone—hematologic cancer	0.00108	0.00593	CrCrCtD
Loteprednol—Methylprednisolone—Prednisolone—hematologic cancer	0.00108	0.00591	CrCrCtD
Loteprednol—Hydrocortisone—Prednisone—hematologic cancer	0.00104	0.00569	CrCrCtD
Loteprednol—Hydrocortisone—Prednisolone—hematologic cancer	0.00102	0.00556	CrCrCtD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—RFXANK—hematologic cancer	0.000694	0.0406	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY2—hematologic cancer	0.000346	0.0202	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY1—hematologic cancer	0.000346	0.0202	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER2—hematologic cancer	0.000346	0.0202	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—hematologic cancer	0.000302	0.0176	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—hematologic cancer	0.000302	0.0176	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—HDAC11—hematologic cancer	0.000288	0.0169	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—GATA2—hematologic cancer	0.000266	0.0156	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER1—hematologic cancer	0.000263	0.0153	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—HDAC10—hematologic cancer	0.000257	0.015	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PER2—hematologic cancer	0.000252	0.0147	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—CRY2—hematologic cancer	0.000252	0.0147	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—CRY1—hematologic cancer	0.000252	0.0147	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—BCL6—hematologic cancer	0.000242	0.0141	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—GATA1—hematologic cancer	0.000229	0.0134	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—RARA—hematologic cancer	0.000209	0.0122	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—GATA2—hematologic cancer	0.000204	0.0119	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—PBX1—hematologic cancer	0.000197	0.0115	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—PER1—hematologic cancer	0.000191	0.0112	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—DUSP5—hematologic cancer	0.00019	0.0111	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—hematologic cancer	0.000189	0.011	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—hematologic cancer	0.000187	0.0109	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CBFB—hematologic cancer	0.000185	0.0108	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MAF—hematologic cancer	0.000185	0.0108	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—NCOR2—hematologic cancer	0.000176	0.0103	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—hematologic cancer	0.000173	0.0101	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—hematologic cancer	0.000173	0.0101	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.00017	0.00994	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—SUMO1—hematologic cancer	0.000166	0.00968	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—RARA—hematologic cancer	0.000166	0.00968	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CBFB—hematologic cancer	0.000165	0.00964	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—SPI1—hematologic cancer	0.000163	0.00955	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—GATA2—hematologic cancer	0.000163	0.00954	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—EOMES—hematologic cancer	0.000161	0.00943	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—hematologic cancer	0.00016	0.00938	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—TCF3—hematologic cancer	0.000157	0.0092	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hematologic cancer	0.000154	0.009	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—CEBPA—hematologic cancer	0.000149	0.00872	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—hematologic cancer	0.000141	0.00825	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—NUP214—hematologic cancer	0.000138	0.00805	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—ARNTL—hematologic cancer	0.000136	0.00796	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—EBF1—hematologic cancer	0.000127	0.00741	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—LEF1—hematologic cancer	0.000124	0.00727	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—hematologic cancer	0.000123	0.00721	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000118	0.00689	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—hematologic cancer	0.000114	0.00668	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hematologic cancer	0.000113	0.00662	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—REL—hematologic cancer	0.00011	0.0064	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—ID3—hematologic cancer	0.000108	0.0063	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—hematologic cancer	0.000107	0.00625	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—hematologic cancer	0.000101	0.00588	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—hematologic cancer	0.0001	0.00586	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—GATA2—hematologic cancer	9.95e-05	0.00581	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—hematologic cancer	9.94e-05	0.00581	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—JUND—hematologic cancer	9.55e-05	0.00558	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MYB—hematologic cancer	9.37e-05	0.00548	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—AR—hematologic cancer	9.36e-05	0.00547	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—hematologic cancer	9.36e-05	0.00547	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	9.32e-05	0.00545	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—DKK1—hematologic cancer	9.04e-05	0.00529	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	9.04e-05	0.00528	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—CREB1—hematologic cancer	8.95e-05	0.00523	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	8.6e-05	0.00503	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—hematologic cancer	8.36e-05	0.00488	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—PTHLH—hematologic cancer	7.88e-05	0.00461	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—RARA—hematologic cancer	7.83e-05	0.00458	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—STAT5B—hematologic cancer	7.73e-05	0.00452	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	7.69e-05	0.00449	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—RET—hematologic cancer	7.59e-05	0.00444	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—AR—hematologic cancer	7.39e-05	0.00432	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CEBPA—hematologic cancer	7.28e-05	0.00426	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CEBPD—hematologic cancer	7.28e-05	0.00426	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—ZNF552—hematologic cancer	7.18e-05	0.0042	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—EZH2—hematologic cancer	7.17e-05	0.00419	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—AR—hematologic cancer	7.17e-05	0.00419	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—hematologic cancer	7.11e-05	0.00416	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL13—hematologic cancer	7.07e-05	0.00413	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—NCOR2—hematologic cancer	6.57e-05	0.00384	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	6.44e-05	0.00376	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	6.42e-05	0.00376	CbGpPWpGaD
Loteprednol—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	6.42e-05	0.00376	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	6.38e-05	0.00373	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	6.11e-05	0.00357	CbGpPWpGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	6.09e-05	0.00356	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—NCOR1—hematologic cancer	6.08e-05	0.00356	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	6.07e-05	0.00355	CbGpPWpGaD
Loteprednol—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	5.98e-05	0.0035	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	5.89e-05	0.00344	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	5.83e-05	0.00341	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	5.75e-05	0.00336	CbGpPWpGaD
Loteprednol—Testosterone Propionate—UGT1A1—hematologic cancer	5.45e-05	0.0465	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	5.42e-05	0.00317	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	5.35e-05	0.00313	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—STAT5B—hematologic cancer	5.34e-05	0.00312	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	5.23e-05	0.00306	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	5.18e-05	0.00303	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	5.14e-05	0.00301	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	5.13e-05	0.003	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	5.11e-05	0.00299	CbGpPWpGaD
Loteprednol—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	5.08e-05	0.00297	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	5.02e-05	0.00293	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	5.02e-05	0.00293	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	4.96e-05	0.0029	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	4.94e-05	0.00289	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	4.88e-05	0.00285	CbGpPWpGaD
Loteprednol—Prednicarbate—NR3C1—hematologic cancer	4.86e-05	0.0414	CrCbGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	4.82e-05	0.00282	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	4.71e-05	0.00275	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	4.7e-05	0.00275	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	4.69e-05	0.00274	CbGpPWpGaD
Loteprednol—Desonide—NR3C1—hematologic cancer	4.6e-05	0.0392	CrCbGaD
Loteprednol—Diflorasone—NR3C1—hematologic cancer	4.6e-05	0.0392	CrCbGaD
Loteprednol—Desoximetasone—NR3C1—hematologic cancer	4.48e-05	0.0382	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	4.46e-05	0.00261	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	4.46e-05	0.00261	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	4.42e-05	0.00258	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—GATA3—hematologic cancer	4.41e-05	0.00258	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	4.37e-05	0.00256	CbGpPWpGaD
Loteprednol—Fludrocortisone—AR—hematologic cancer	4.37e-05	0.0373	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	4.35e-05	0.00254	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	4.31e-05	0.00252	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	4.31e-05	0.00252	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—CREB1—hematologic cancer	4.3e-05	0.00251	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	4.3e-05	0.00251	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	4.22e-05	0.00247	CbGpPWpGaD
Loteprednol—NR3C1—Circadian Clock—CREBBP—hematologic cancer	4.19e-05	0.00245	CbGpPWpGaD
Loteprednol—Medrysone—NR3C1—hematologic cancer	4.07e-05	0.0347	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	3.94e-05	0.0023	CbGpPWpGaD
Loteprednol—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	3.92e-05	0.00229	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	3.9e-05	0.00228	CbGpPWpGaD
Loteprednol—Testosterone Propionate—AR—hematologic cancer	3.89e-05	0.0332	CrCbGaD
Loteprednol—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	3.89e-05	0.00227	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	3.81e-05	0.00223	CbGpPWpGaD
Loteprednol—Hydrocortamate—NR3C1—hematologic cancer	3.8e-05	0.0324	CrCbGaD
Loteprednol—Cortisone acetate—NR3C1—hematologic cancer	3.74e-05	0.0319	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	3.73e-05	0.00218	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	3.67e-05	0.00214	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—STAT1—hematologic cancer	3.62e-05	0.00211	CbGpPWpGaD
Loteprednol—Fluoxymesterone—AR—hematologic cancer	3.61e-05	0.0308	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	3.55e-05	0.00208	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	3.55e-05	0.00207	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	3.54e-05	0.00207	CbGpPWpGaD
Loteprednol—Budesonide—NR3C1—hematologic cancer	3.53e-05	0.0301	CrCbGaD
Loteprednol—Amcinonide—NR3C1—hematologic cancer	3.53e-05	0.0301	CrCbGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	3.52e-05	0.00206	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	3.51e-05	0.00205	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	3.47e-05	0.00203	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ZNF552—hematologic cancer	3.46e-05	0.00202	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	3.42e-05	0.002	CbGpPWpGaD
Loteprednol—Mometasone—NR3C1—hematologic cancer	3.36e-05	0.0286	CrCbGaD
Loteprednol—Rimexolone—NR3C1—hematologic cancer	3.32e-05	0.0283	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—STAT5A—hematologic cancer	3.25e-05	0.0019	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	3.19e-05	0.00186	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	3.16e-05	0.00185	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	3.16e-05	0.00184	CbGpPWpGaD
Loteprednol—Beclomethasone—NR3C1—hematologic cancer	3.13e-05	0.0267	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	3.13e-05	0.00183	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	3.12e-05	0.00183	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	3.07e-05	0.0018	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—NCOR1—hematologic cancer	3.06e-05	0.00179	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	3.04e-05	0.00178	CbGpPWpGaD
Loteprednol—Alclometasone—NR3C1—hematologic cancer	3.04e-05	0.026	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	3.02e-05	0.00177	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	3.02e-05	0.00177	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	3.01e-05	0.00176	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—FOXO1—hematologic cancer	2.98e-05	0.00174	CbGpPWpGaD
Loteprednol—Flunisolide—NR3C1—hematologic cancer	2.96e-05	0.0253	CrCbGaD
Loteprednol—Clobetasol propionate—NR3C1—hematologic cancer	2.96e-05	0.0253	CrCbGaD
Loteprednol—Fludrocortisone—NR3C1—hematologic cancer	2.96e-05	0.0253	CrCbGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	2.95e-05	0.00172	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	2.94e-05	0.00172	CbGpPWpGaD
Loteprednol—Paramethasone—NR3C1—hematologic cancer	2.93e-05	0.0249	CrCbGaD
Loteprednol—Methyltestosterone—AR—hematologic cancer	2.91e-05	0.0248	CrCbGaD
Loteprednol—Ciclesonide—NR3C1—hematologic cancer	2.88e-05	0.0245	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	2.86e-05	0.00167	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	2.86e-05	0.00167	CbGpPWpGaD
Loteprednol—Fluorometholone—NR3C1—hematologic cancer	2.86e-05	0.0244	CrCbGaD
Loteprednol—NR3C1—Circadian Clock—EP300—hematologic cancer	2.85e-05	0.00167	CbGpPWpGaD
Loteprednol—Fluoxymesterone—ESR1—hematologic cancer	2.78e-05	0.0237	CrCbGaD
Loteprednol—Methylprednisolone—NR3C1—hematologic cancer	2.76e-05	0.0235	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—FAS—hematologic cancer	2.74e-05	0.0016	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	2.68e-05	0.00157	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	2.66e-05	0.00155	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	2.66e-05	0.00155	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	2.64e-05	0.00154	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	2.62e-05	0.00153	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—CASC3—hematologic cancer	2.62e-05	0.00153	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	2.6e-05	0.00152	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.59e-05	0.00151	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.56e-05	0.00149	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.55e-05	0.00149	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	2.47e-05	0.00144	CbGpPWpGaD
Loteprednol—Fluoxymesterone—NR3C1—hematologic cancer	2.45e-05	0.0209	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	2.4e-05	0.0014	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	2.35e-05	0.00138	CbGpPWpGaD
Loteprednol—Triamcinolone—NR3C1—hematologic cancer	2.33e-05	0.0199	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	2.31e-05	0.00135	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	2.27e-05	0.00133	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	2.25e-05	0.00131	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	2.2e-05	0.00129	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	2.18e-05	0.00127	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CREB1—hematologic cancer	2.16e-05	0.00126	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	2.13e-05	0.00124	CbGpPWpGaD
Loteprednol—Prednisone—NR3C1—hematologic cancer	2.11e-05	0.018	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—RB1—hematologic cancer	2.1e-05	0.00123	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	2.09e-05	0.00122	CbGpPWpGaD
Loteprednol—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	2.09e-05	0.00122	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	2.07e-05	0.00121	CbGpPWpGaD
Loteprednol—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.06e-05	0.0012	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	2.05e-05	0.0012	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	2.04e-05	0.0012	CbGpPWpGaD
Loteprednol—Prednisolone—NR3C1—hematologic cancer	1.95e-05	0.0166	CrCbGaD
Loteprednol—Betamethasone—NR3C1—hematologic cancer	1.91e-05	0.0163	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.87e-05	0.00109	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.86e-05	0.00109	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.82e-05	0.00107	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.82e-05	0.00107	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.82e-05	0.00106	CbGpPWpGaD
Loteprednol—Hydrocortisone—ABCG2—hematologic cancer	1.73e-05	0.0147	CrCbGaD
Loteprednol—NR3C1—Gene Expression—RARS—hematologic cancer	1.69e-05	0.000987	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.68e-05	0.000984	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.59e-05	0.000928	CbGpPWpGaD
Loteprednol—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.54e-05	0.000901	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.53e-05	0.000893	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.51e-05	0.000881	CbGpPWpGaD
Loteprednol—Hydrocortisone—NR3C1—hematologic cancer	1.49e-05	0.0127	CrCbGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.48e-05	0.000867	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.39e-05	0.00081	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.38e-05	0.000808	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—TET2—hematologic cancer	1.38e-05	0.000805	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—RARA—hematologic cancer	1.38e-05	0.000805	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.36e-05	0.000794	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.35e-05	0.000789	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.34e-05	0.000786	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.34e-05	0.000785	CbGpPWpGaD
Loteprednol—Methylprednisolone—ABCB1—hematologic cancer	1.33e-05	0.0114	CrCbGaD
Loteprednol—Dexamethasone—ABCG2—hematologic cancer	1.29e-05	0.011	CrCbGaD
Loteprednol—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.28e-05	0.000748	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.28e-05	0.000747	CbGpPWpGaD
Loteprednol—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.26e-05	0.000739	CbGpPWpGaD
Loteprednol—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.25e-05	0.000732	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.25e-05	0.000728	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.24e-05	0.000724	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.22e-05	0.000714	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ELL—hematologic cancer	1.2e-05	0.000703	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.18e-05	0.000688	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.17e-05	0.000686	CbGpPWpGaD
Loteprednol—NR3C1—Adipogenesis—TNF—hematologic cancer	1.16e-05	0.00068	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NCOR2—hematologic cancer	1.16e-05	0.000675	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	1.12e-05	0.000653	CbGpPWpGaD
Loteprednol—Dexamethasone—NR3C1—hematologic cancer	1.11e-05	0.00946	CrCbGaD
Loteprednol—Prednisone—ALB—hematologic cancer	1.07e-05	0.0091	CrCbGaD
Loteprednol—NR3C1—Gene Expression—AGO2—hematologic cancer	1.07e-05	0.000623	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—DNMT3B—hematologic cancer	1.04e-05	0.00061	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—H3F3B—hematologic cancer	1.04e-05	0.00061	CbGpPWpGaD
Loteprednol—Prednisone—ABCB1—hematologic cancer	1.02e-05	0.00869	CrCbGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.01e-05	0.000588	CbGpPWpGaD
Loteprednol—Methyltestosterone—ALB—hematologic cancer	9.99e-06	0.00852	CrCbGaD
Loteprednol—NR3C1—Gene Expression—RPS14—hematologic cancer	9.54e-06	0.000558	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NUP98—hematologic cancer	9.39e-06	0.000549	CbGpPWpGaD
Loteprednol—Prednisolone—ABCB1—hematologic cancer	9.39e-06	0.00801	CrCbGaD
Loteprednol—NR3C1—Adipogenesis—IL6—hematologic cancer	9.39e-06	0.000549	CbGpPWpGaD
Loteprednol—Betamethasone—ABCB1—hematologic cancer	9.2e-06	0.00785	CrCbGaD
Loteprednol—NR3C1—Gene Expression—NUP214—hematologic cancer	9.06e-06	0.000529	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	8.77e-06	0.000513	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	8.48e-06	0.000496	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	8.34e-06	0.000488	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—HSPB1—hematologic cancer	8.34e-06	0.000488	CbGpPWpGaD
Loteprednol—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	8.12e-06	0.000474	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—SMC1A—hematologic cancer	7.99e-06	0.000467	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—H3F3A—hematologic cancer	7.83e-06	0.000458	CbGpPWpGaD
Loteprednol—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	7.69e-06	0.000449	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—EZH2—hematologic cancer	7.51e-06	0.000439	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—PARP1—hematologic cancer	7.35e-06	0.00043	CbGpPWpGaD
Loteprednol—Hydrocortisone—ABCB1—hematologic cancer	7.18e-06	0.00612	CrCbGaD
Loteprednol—NR3C1—Gene Expression—HDAC2—hematologic cancer	7.09e-06	0.000415	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AR—hematologic cancer	6.15e-06	0.000359	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—CDKN2B—hematologic cancer	5.67e-06	0.000331	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NCOR1—hematologic cancer	5.37e-06	0.000314	CbGpPWpGaD
Loteprednol—Dexamethasone—ABCB1—hematologic cancer	5.35e-06	0.00456	CrCbGaD
Loteprednol—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	4.56e-06	0.000267	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—MAPK14—hematologic cancer	4.3e-06	0.000252	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—ESR1—hematologic cancer	4.22e-06	0.000247	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—NOTCH1—hematologic cancer	4.08e-06	0.000239	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—CREBBP—hematologic cancer	3.7e-06	0.000216	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.26e-06	0.000132	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—MYC—hematologic cancer	2.2e-06	0.000128	CbGpPWpGaD
Loteprednol—NR3C1—Gene Expression—AKT1—hematologic cancer	1.52e-06	8.9e-05	CbGpPWpGaD
